Phenol is an important industrial commodity, but the current production method has serious drawbacks related to safety, selectivity, and formation.

To address this issue, Prof. Ronny Neumann, Faculty of Chemistry, Molecular Chemistry and Materials Science at the Weizmann Institute of Science, recently developed a new phenol production method.

Based on electrocatalytic oxidation of benzene, the new production method is not only simple, efficient, and cost-effective, but it is a lot safer, too.

The project partners Weizmann Institute of Science and Acceler8 Venture Builder have met in Rehovot - Israel to prepare the 3-year #EICTransition project funded by the #EU.

eBeam4Therapy aims to revolutionise #radiotherapy with a new approach based on very high energy electrons (VHEE), generated by laser plasma accelerators. This will provide better clinical outcomes and radically improve the quality of life of #cancer patients.

We are honored and delighted to share that The Weizmann Institute of Science is ranked number 8 on the Leiden global ranking (CWTS) of all scientific institutions and universities across the world.

YEDA continues to protect and commercialize innovations made possible only by scientists at Weizmann Institute of Science. Kudos!

Congratulations to UltraSight, an Israeli-based digital health pioneer and Yeda spinoff, on obtaining a CE Mark for transforming cardiac imaging through the power of its ultrasound AI guidance software.
"UltraSight's technology allows medical professionals, regardless of their sonography experience, to successfully capture diagnostic quality ultrasound images of the heart."
Using Philips Lumify ultrasound device, UltraSight CE Mark was obtained following positive results from a clinical study at Sheba Medical Center, Israel, validating the technology and its effectiveness.

Subdural hematoma (SDH) is a collection of blood between the inner layer of the dura and the brain that occurs mostly as a result of trauma. It is one of the most common neurosurgical conditions in the United States today. SDH monitoring for hematoma expansion would be beneficial to enable expeditious surgical intervention.

In a study to better understand how to treat inflammatory bowel disease at the Weizmann Institute of Science. Led by the group of Prof. Eran Elinav of the Systems Immunology Department, in collaboration with the Molecular Genetics Department’s Prof. Rotem Sorek and a Weizmann spinoff company - BiomX Inc., published their findings in the prestigious journal Cell.

ד"ר רותי בן שלומי וד"ר חן טרדונסקי עבדו באותו המסדרון במכון ויצמן והתעניינו באותה בעיה עד שהחליטו לשלב כוחות ולבנות מחשב על: "לייטסולבר" הוא מחשב אופטי מבוסס קרני לייזר והוא יכול לתרום לפתרון בעיות מסובכות בלוגיסטיקה, רפואה, בטחון ועוד. בן שלומי: "אנחנו לא המחשב האופטי הראשון בעולם אבל בכל המתחרים יש אלקטרוניקה, והיא הופכת לצוואר הבקבוק"

LightSolver is a spinoff of Yeda from the Weizmann Institute of Science

Yeda spinoff, Xinteza API, has recently revealed a new source of cannabinoid biosynthesis that does not involve cannabinoids or cannabis. This breakthrough was discovered in research led by Professor Asaph Aharoni, Scientific Co-Founder of Xinteza and Head of the Weizmann Institute of Science Plant Metabolics Lab as well as Head of Weizmann’s Plant and Environmental Sciences Department.

“This discovery is a major milestone in the path to uncover and exploit rare and new cannabinoid molecules with potentially novel pharmacological activities”, says Aharoni.

A seed investment has been made in ClimateCrop - photosynthesis enhancement Ltd, a spinoff from Yeda, using state-of-the-art gene editing techniques to improve plant growth efficiency.